TNFalpha blockade in human diseases: an overview of efficacy and safety.
about
Cherubism: best clinical practiceReview article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel diseaseRegulation of tumour necrosis factor signalling: live or let dieProtectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolomeDiscovery of novel orally active anti-inflammatory N-phenylpyrazolyl-N-glycinyl-hydrazone derivatives that inhibit TNF-α productionInvasive fungal infections in pediatric patients treated with tumor necrosis alpha (TNF-α) inhibitorsDemyelinating Disease following Anti-TNFa Treatment: A Causal or Coincidental Association? Report of Four Cases and Review of the Literature.Pathway analysis of GWAS provides new insights into genetic susceptibility to 3 inflammatory diseases.Autoimmune disease classification by inverse association with SNP alleles.The protective antibodies induced by a novel epitope of human TNF-alpha could suppress the development of collagen-induced arthritis.IL-1beta processing in host defense: beyond the inflammasomes.Phospholipase D1 mediates TNFalpha-induced inflammation in a murine model of TNFalpha-induced peritonitis.Optic neuritis associated with adalimumab in the treatment of uveitis.Therapeutic effect of intensive granulocyte and monocyte adsorption apheresis combined with thiopurines for steroid- and biologics-naïve Japanese patients with early-diagnosed Crohn's disease.Neurological disorders and inflammatory bowel diseasesEtanercept attenuates myocardial ischemia/reperfusion injury by decreasing inflammation and oxidative stress.Pharmacotherapy for uveitis: current management and emerging therapy.Inflammation in the pathogenesis of microvascular complications in diabetes.Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological study.Accelerated pathological and clinical nephritis in systemic lupus erythematosus-prone New Zealand Mixed 2328 mice doubly deficient in TNF receptor 1 and TNF receptor 2 via a Th17-associated pathwayNovel proresolving aspirin-triggered DHA pathwayInactivation of TNF-α ameliorates diabetic neuropathy in mice.Pathological role of fractalkine/CX3CL1 in rheumatic diseases: a unique chemokine with multiple functions.Disrupted Signaling through the Fanconi Anemia Pathway Leads to Dysfunctional Hematopoietic Stem Cell Biology: Underlying Mechanisms and Potential Therapeutic Strategies.Emerging drugs for the treatment of ulcerative colitisTumor necrosis factor-α synthesis inhibitor 3,6'-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer's diseaseAcquired latent tuberculosis infection in psoriasis patients treated with etanercept in the People's Republic of China.What do effective treatments for multiple sclerosis tell us about the molecular mechanisms involved in pathogenesis?TNFalpha blockade in human diseases: mechanisms and future directions.The risk of herpes zoster in the anti-TNF-α era: a case report and review of the literature.Tumor necrosis factor α antagonism improves neurological recovery in murine intracerebral hemorrhage.Cancer risk in immune-mediated inflammatory diseases (IMID).Infectious complications associated with monoclonal antibodies and related small moleculesEctopic HOXB4 overcomes the inhibitory effect of tumor necrosis factor-{alpha} on Fanconi anemia hematopoietic stem and progenitor cells.TNF-α Promoter Polymorphisms Predict the Response to Etanercept More Powerfully than that to Infliximab/Adalimumab in Spondyloarthritis.Pharmacological characterization of PF-00547659, an anti-human MAdCAM monoclonal antibodyWhy can't we find a new treatment for SLE?TNFR1 signaling kinetics: spatiotemporal control of three phases of IKK activation by posttranslational modification.Immunotherapy of autoimmunity and cancer: the penalty for success.Anakinra for myocarditis in juvenile idiopathic arthritis.
P2860
Q21202854-F9D90943-B18B-4408-95E5-6603E63241F5Q26822029-09EE69AE-88B5-496D-AF94-4554DFCD6A5DQ28262381-E4773BCB-3955-495E-BCB9-EA62B894E4BFQ28387661-33B0FB4B-0DBC-40A9-AA17-DADB75EA20CBQ28484258-846FF0D8-637D-41E2-9638-E038F2EC7CE0Q29302324-EB49AD90-D7CE-489F-BBAE-58234A2841A1Q30647378-1DC020E1-C74F-48FC-B7A8-ACB3AED28B61Q30943588-1C261024-0F46-45BF-8601-78F6595463A2Q33521311-C33E174E-009D-4873-A7FD-75A0C5D5CE9CQ33527432-2ED840F8-698F-4B2D-A0B0-5459EE8A10E1Q33535878-D4AD6060-1C7E-48D0-9F54-65422806846AQ33576859-5261557A-30A7-4213-B44B-11A6B2384D42Q33681462-55AA2A97-8F54-49DC-8B10-8E029D415652Q33926396-ADE34DE6-4769-42FE-8AE7-45FFB883FE06Q33958822-13CC5EA2-2AE4-4468-B016-53B43B51DAF3Q34258212-EF565D5E-057D-47D5-9F6C-995CD16778C9Q34274075-40D751B3-31F5-43C3-8607-3E52606F55E2Q34319638-9D0E1534-73D3-4140-A74F-7377051EBD36Q34501045-C68EA970-6136-412B-9682-91FA3319109BQ34939962-12338E6E-1782-4874-B894-BF6C53E6DDD4Q35189668-2A6A9447-5432-43EC-A5CF-960302BA0AFDQ35543628-40302D6E-BE3C-4984-A73D-A5FB4306992CQ35927383-340EF839-41F5-4C9C-8FEF-8C2B0AC78DFBQ36004703-73A23258-833E-40A3-9CC6-9B225936E289Q36039436-E270627A-0FD8-48B6-9AC4-364D7B58CA69Q36118204-92A1C5B2-C1F0-44ED-A549-6551E41F776EQ36176854-D5847F54-0DC2-423A-AF95-81DC3B111B73Q36396476-91A8DAC9-8DB6-4B07-ABD7-74C9F480D2B6Q36536886-B743FC4D-41FC-4A24-B294-837A2A52D353Q36755236-3B416C20-B948-4E1F-9F33-9C42321828B2Q37152242-77753DF8-69B2-4202-82F8-EE58E3040DD1Q37153407-91B30ADF-9202-4016-9F01-DFBBA364FA27Q37156636-5CECEA11-5AC6-44BB-8CE4-457C368DE3E4Q37201960-EDEA34B8-DC70-4C22-A97A-423DF0FC6C3FQ37220061-DB10EB8F-A4F9-4422-90D3-4E611E9090FBQ37230907-21B6A8C0-1144-40F5-BA56-868C578117B4Q37236049-5CE4FB2E-4ED0-4F17-AF54-6E836DE05FA5Q37299479-E46855FC-A68C-4BFD-8992-F6886E64C979Q37325451-30A86FD1-6B34-4D13-B005-008C97D06BB6Q37369987-9DFB2CC3-4D81-4D1C-A6CC-8BDA85C5577A
P2860
TNFalpha blockade in human diseases: an overview of efficacy and safety.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
TNFalpha blockade in human diseases: an overview of efficacy and safety.
@ast
TNFalpha blockade in human diseases: an overview of efficacy and safety.
@en
type
label
TNFalpha blockade in human diseases: an overview of efficacy and safety.
@ast
TNFalpha blockade in human diseases: an overview of efficacy and safety.
@en
prefLabel
TNFalpha blockade in human diseases: an overview of efficacy and safety.
@ast
TNFalpha blockade in human diseases: an overview of efficacy and safety.
@en
P2093
P2860
P1433
P1476
TNFalpha blockade in human diseases: an overview of efficacy and safety.
@en
P2093
David Gjertson
David Ziring
Elaine Reed
Jonathan Braun
Maida Wong
Ram Raj Singh
Sheetal Desai
Sungjin Kim
Yael Korin
P2860
P356
10.1016/J.CLIM.2007.08.012
P577
2007-10-04T00:00:00Z